Company: LPSN
Filing Date: 2025-09-15
Form Type: DEFA14A
Source: 0001102993-25-000156
Chunk: 5

Company: LIVEPERSON INC
Filing Date: 2025-09-15
Form: DEFA14A
Chunk 5
---
 stockholders, each outstanding share of Series B Preferred Stock will automatically convert into 874.452714 shares of Common Stock (the “Conversion Ratio”, subject to proportional adjustment for any splits, combination, or similar adjustments, and such shares of Common Stock, “Conversion Shares”) within one business day following the filing and acceptance of the Charter Amendment with the Secretary of State of the State of Delaware (the “Conversion”), subject to the Beneficial Ownership Limitation. In the event that the Charter Amendment is not approved by the Company’s stockholders, the Series B Preferred Stock will remain outstanding. Each share of Series B Preferred Stock is entitled to a number of votes equal the number of Conversion Shares into which such share of Series B Preferred Stock is convertible (subject to the Beneficial Ownership Limitation), and is entitled to vote on all matters submitted for voting to the common stockholders, including the Charter Amendment described above. Pursuant to the Exchange Agreement, the Noteholders delivered an irrevocable proxy to John D. Collins and Monica L. Greenberg, members of the Company’s management team and designated proxy holders for the Special Meeting (as defined below), on the Closing Date to vote their Common Equity Shares and shares of Series B Preferred Stock in favor of the Charter Amendment. In addition, the consent of the holders of a majority of shares of then-outstanding Series B Preferred Stock, voting together as single class, will be required for: (i) the alteration or change to the powers, preferences or rights given to the Series B Preferred Stock, (ii) the amendment or repeal any provision of, or addition of any provision to, the Certificate of Incorporation or the Fourth Amended and Restated By-Laws of the Company, or the filing of any articles of amendment, certificate of designations, preferences, limitations and relative rights of any series of preferred stock, if such action would materially and adversely alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Series B Preferred Stock; or (iii) the declaration or payment of any dividends on any junior securities, including any Common Stock, during any time that all accrued dividends on the Series B Preferred Stock have not been paid in full in cash. In the event of any Fundamental Transaction (as defined in the Certificate of Designation) or voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (a “Liquidation Event”), holders of the Series B Preferred Stock shall be entitled, out of assets legally available therefor,